Literature DB >> 16689757

Accuracy of clinical decision rule, D-dimer and spiral computed tomography in patients with malignancy, previous venous thromboembolism, COPD or heart failure and in older patients with suspected pulmonary embolism.

M Sohne1, M J H A Kruip, M Nijkeuter, L Tick, H Kwakkel, S J M Halkes, M V Huisman, H R Buller.   

Abstract

BACKGROUND: The diagnostic work-up of patients with suspected pulmonary embolism (PE) has been optimized and simplified by the use of clinical decision rules (CDR), D-dimer (DD) testing and spiral computed tomography (s-CT). Whether this strategy is equally safe and efficient in specific subgroups of patients is evaluated in this study.
METHODS: A diagnostic strategy including a CDR, DD test and s-CT was evaluated in patients with malignancy, previous venous thromboembolism (VTE), chronic obstructive pulmonary disease or heart failure and in older patients. PE was ruled out by either an unlikely CDR and a normal DD or a s-CT negative for PE. The safety of these tests was assessed by the 3-month incidence rate of symptomatic VTE in those without PE at baseline. The efficiency was evaluated by calculating the numbers needed to test for the different subgroups.
RESULTS: The venous thromboembolic incidence rate after the combination of an unlikely CDR and a normal DD varied from 0% (95% CI: 0-7.9%) in the 482 patients older than 75 years of age to 2% (95% CI: 0.05-10.9%) in the 474 patients with a malignancy. For s-CT these incidences varied from 0.3% to 1.8%. The number needed to test in order to rule out one patient from PE with the studied strategy was highest in cancer patients and in the elderly patients (approximately 10).
CONCLUSION: It appears to be safe to rule out PE by either the combination of an unlikely CDR and a normal DD or by a negative s-CT in various subgroups of patients with suspected PE. However, the clinical usefulness of the CDR in combination with the DD as the initial step in the diagnostic process varied among these patient groups.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16689757     DOI: 10.1111/j.1538-7836.2006.01918.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  18 in total

Review 1.  Acute pulmonary embolism. Part 1: epidemiology and diagnosis.

Authors:  Renée A Douma; Pieter W Kamphuisen; Harry R Büller
Journal:  Nat Rev Cardiol       Date:  2010-07-20       Impact factor: 32.419

2.  Should the cut-off value of D-dimer be elevated to exclude pulmonary embolism in acute exacerbation of COPD?

Authors:  Evrim Eylem Akpinar; Derya Hoşgün; Beyza Doğanay; Gökçe Kaan Ataç; Meral Gülhan
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

3.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

4.  Catheter-related thrombosis: A practical approach.

Authors:  Caroline Wall; John Moore; Jecko Thachil
Journal:  J Intensive Care Soc       Date:  2015-12-03

5.  Increased d-dimer levels predict cardiovascular mortality in patients with systolic heart failure.

Authors:  Ali Zorlu; Mehmet Birhan Yilmaz; Hasan Yucel; Gokhan Bektasoglu; Meltem Refiker Ege; Izzet Tandogan
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

6.  Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease?

Authors:  Olivier T Rutschmann; Jacques Cornuz; Pierre-Alexandre Poletti; Pierre-Olivier Bridevaux; Olivier W Hugli; Salah D Qanadli; Arnaud Perrier
Journal:  Thorax       Date:  2006-11-13       Impact factor: 9.139

7.  Usefulness of Clinical Prediction Rules, D-dimer, and Arterial Blood Gas Analysis to Predict Pulmonary Embolism in Cancer Patients.

Authors:  Asifa Karamat; Shazia Awan; Muhammad Ghazanfar Hussain; Fahad Al Hameed; Faheem Butt; Ali Saeed Wahla
Journal:  Oman Med J       Date:  2017-03

8.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism.

Authors:  Wendy Lim; Grégoire Le Gal; Shannon M Bates; Marc Righini; Linda B Haramati; Eddy Lang; Jeffrey A Kline; Sonja Chasteen; Marcia Snyder; Payal Patel; Meha Bhatt; Parth Patel; Cody Braun; Housne Begum; Wojtek Wiercioch; Holger J Schünemann; Reem A Mustafa
Journal:  Blood Adv       Date:  2018-11-27

9.  Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts.

Authors:  Renée A Douma; Grégoire le Gal; Maaike Söhne; Marc Righini; Pieter W Kamphuisen; Arnaud Perrier; Marieke J H A Kruip; Henri Bounameaux; Harry R Büller; Pierre-Marie Roy
Journal:  BMJ       Date:  2010-03-30

10.  Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination.

Authors:  Ranjith Shetty; Ali Seddighzadeh; Gregory Piazza; Samuel Z Goldhaber
Journal:  J Thromb Thrombolysis       Date:  2007-10-17       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.